Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature
Frontiers in Endocrinology - Switzerland
doi 10.3389/fendo.2020.00061
Full Text
Open PDFAbstract
Available in full text
Date
February 18, 2020
Authors
Publisher
Frontiers Media SA